Literature DB >> 24929171

Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In regard to Brown et al.

Shyam S Rao1, Jung Hun Oh2, Andrew Jackson2, Joseph O Deasy2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24929171      PMCID： PMC4822491          DOI： 10.1016/j.ijrobp.2014.03.027

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  3 in total

Review 1.  The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

Authors:  J Martin Brown; David J Carlson; David J Brenner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

2.  Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control.

Authors:  Niraj Mehta; Christopher R King; Nzhde Agazaryan; Michael Steinberg; Amanda Hua; Percy Lee
Journal:  Pract Radiat Oncol       Date:  2011-12-03

3.  Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.

Authors:  J Martin Brown; David J Brenner; David J Carlson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-04-01       Impact factor: 7.038
  3 in total
  3 in total

1.  Dose escalation in the definite target volume.

Authors:  W Tyler Watkins; Hamidreza Nourzadeh; Jeffrey V Siebers
Journal:  Med Phys       Date:  2020-05-11       Impact factor: 4.071

2.  Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules.

Authors:  Jeho Jeong; Jung Hun Oh; Jan-Jakob Sonke; Jose Belderbos; Jeffrey D Bradley; Andrew N Fontanella; Shyam S Rao; Joseph O Deasy
Journal:  Clin Cancer Res       Date:  2017-05-24       Impact factor: 12.531

3.  Potential Clinical Significance of Overall Targeting Accuracy and Motion Management in the Treatment of Tumors That Move With Respiration: Lessons Learnt From a Quarter Century of Stereotactic Body Radiotherapy From Dose Response Models.

Authors:  Anand Mahadevan; Bahman Emami; Jimm Grimm; Lawrence R Kleinberg; Kristin J Redmond; James S Welsh; Robert Rostock; Eric Kemmerer; Kenneth M Forster; Jason Stanford; Sunjay Shah; Sucha O Asbell; Tamara A LaCouture; Carla Scofield; Ian Butterwick; Jinyu Xue; Alexander Muacevic; John R Adler
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.